Article Versions Notes

Vena A, Giacobbe DR, Castaldo N, Cattelan A, Mussini C, Luzzati R, De Rosa FG, Puente FD, Mastroianni CM, Cascio A, et al. Clinical Experience with Ceftazidime-Avibactam for the Treatment of Infections due to Multidrug-Resistant Gram-Negative Bacteria Other than Carbapenem-Resistant Enterobacterales. Antibiotics. 2020; 9(2):71. https://doi.org/10.3390/antibiotics9020071

Vena, Antonio, Daniele Roberto Giacobbe, Nadia Castaldo, Annamaria Cattelan, Cristina Mussini, Roberto Luzzati, Francesco Giuseppe De Rosa, Filippo Del Puente, Claudio Maria Mastroianni, Antonio Cascio, and et al. 2020. "Clinical Experience with Ceftazidime-Avibactam for the Treatment of Infections due to Multidrug-Resistant Gram-Negative Bacteria Other than Carbapenem-Resistant Enterobacterales" Antibiotics 9, no. 2: 71. https://doi.org/10.3390/antibiotics9020071

Vena, A., Giacobbe, D. R., Castaldo, N., Cattelan, A., Mussini, C., Luzzati, R., De Rosa, F. G., Puente, F. D., Mastroianni, C. M., Cascio, A., Carbonara, S., Capone, A., Boni, S., Sepulcri, C., Meschiari, M., Raumer, F., Oliva, A., Corcione, S., Bassetti, M., & for the Ceftabuse Study Group. (2020). Clinical Experience with Ceftazidime-Avibactam for the Treatment of Infections due to Multidrug-Resistant Gram-Negative Bacteria Other than Carbapenem-Resistant Enterobacterales. Antibiotics, 9(2), 71. https://doi.org/10.3390/antibiotics9020071